...
机译:用于干细胞衍生的β细胞替代疗法的纳米多孔免疫保护装置
UCSF UC Berkeley Joint PhD Program Bioengn San Francisco CA 94143 USA;
Univ Calif San Francisco Dept Surg San Francisco CA 94143 USA;
Univ Calif San Francisco Diabet Ctr San Francisco CA 94143 USA;
Univ Calif San Francisco Diabet Ctr San Francisco CA 94143 USA;
Univ Calif San Francisco Dept Bioengn &
Therapeut Sci San Francisco CA 94143 USA;
Univ Calif San Francisco Dept Bioengn &
Therapeut Sci San Francisco CA 94143 USA;
Univ Calif San Francisco Dept Bioengn &
Therapeut Sci San Francisco CA 94143 USA;
Univ Calif San Francisco Diabet Ctr San Francisco CA 94143 USA;
Univ Calif San Francisco Diabet Ctr San Francisco CA 94143 USA;
Univ Calif San Francisco Dept Surg San Francisco CA 94143 USA;
UCSF UC Berkeley Joint PhD Program Bioengn San Francisco CA 94143 USA;
cell encapsulation device; cell therapy; nanotechnology; immunoengineering diabetes;
机译:用于干细胞衍生的β细胞替代疗法的纳米多孔免疫保护装置
机译:解决1型糖尿病β细胞替代疗法的免疫耐受性难题
机译:从IPSCS产生胰腺β细胞及其患者1型糖尿病替代治疗和建模的潜力
机译:用于细胞基疗法的一体的可生物降解,免疫保护,双纳米多孔胶囊
机译:电动门控纳米孔膜,用于智能药物输送和生物医学设备
机译:用于干细胞衍生的β细胞替代疗法的纳米孔免疫保护装置
机译:纳米多孔免疫保护装置用于干细胞衍生的β细胞替代疗法